| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.06. | United Dogecoin erwirbt Mining-Flotte und strebt Betriebsaufnahme an | 15 | Investing.com Deutsch | ||
| 26.06. | United Dogecoin purchases mining fleet, targets operations start | 1 | Investing.com | ||
| 26.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site | 381 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle... ► Artikel lesen | |
| 25.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting | 624 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 25, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining and digital infrastructure company driven by industry experts... ► Artikel lesen | |
| 11.06. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 09.06. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time | 650 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 9, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence... ► Artikel lesen | |
| 27.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs | 794 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously... ► Artikel lesen | |
| 14.05. | Shuttle Pharma completes merger with United Dogecoin | 2 | Investing.com | ||
| 01.05. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | 871 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 01.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner | 951 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 31.03. | Shuttle Pharmaceuticals Holdings, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 26.03. | Shuttle Pharma expands AI drug discovery platform capabilities | 4 | Investing.com | ||
| 26.03. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | 629 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its... ► Artikel lesen | |
| 12.03. | E.F. Hutton places $3.5M offering for Shuttle Pharmaceuticals | 1 | Investing.com | ||
| 12.03. | E.F. Hutton begleitet Kapitalerhöhung von Shuttle Pharmaceuticals über 3,5 Mio. US-Dollar | 1 | Investing.com Deutsch | ||
| 06.03. | Shuttle Pharmaceuticals announces $3.5 million public offering | 1 | Seeking Alpha | ||
| 06.03. | Shuttle Pharmaceuticals sichert sich 3,5 Mio. US-Dollar durch öffentliche Platzierung | 1 | Investing.com Deutsch | ||
| 06.03. | Shuttle Pharmaceuticals raises $3.5M in public offering | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TILRAY BRANDS | 4,050 | +0,37 % | Tilray Brands, Inc.: Hi*Ball Energy Powers into the English Football League with Wolverhampton Wanderers Partnership | English Football League partnership expands Hi*Ball's UK presence, bringing the clean, zero-sugar sparkling energy brand to one of football's most passionate fanbases
LONDON, Aug. 11, 2026 (GLOBE... ► Artikel lesen | |
| VIATRIS | 13,994 | -0,28 % | Viatris Posts Wider Loss In Q2; Raises 2026 Guidance | WASHINGTON (dpa-AFX) - Viatris Inc. (VTRS) reported a second-quarter net loss of $118.8 million compared to a net loss of $4.6 million, a year ago. GAAP diluted loss per share was $0.10 compared... ► Artikel lesen | |
| SYNBIOTIC | 0,821 | -8,78 % | EQS-Adhoc: SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung von Insolvenzverfahren zu stellen | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Strategische Unternehmensentscheidung/Insolvenz
SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 10,895 | -0,77 % | Tonix Pharma auf Canaccord-Genuity-Konferenz: Markteinführung gewinnt an Dynamik | ||
| SELLAS LIFE SCIENCES | 11,100 | +0,45 % | SELLAS Life Sciences Group, Inc. - 8-K, Current Report | ||
| XORTX THERAPEUTICS | 1,848 | +1,20 % | XORTX Therapeutics Inc.: XORTX Announces Director Resignation | CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | |
| SOLIGENIX | 0,400 | 0,00 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results | PRINCETON, N.J., Aug. 7, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a biopharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
| TALPHERA | 1,030 | -2,83 % | Talphera falls despite narrower Q2 loss, NEPHRO trial progress | ||
| SAVARA | 4,610 | 0,00 % | Savara Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| SCYNEXIS | 4,600 | +3,02 % | XFRA 135: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,235 | +3,66 % | Theriva Biologics, Inc.: Theriva Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results | - First patients dosed in the VIRAGE2 Phase 2a clinical study evaluating more frequent repeated dosing of VCN-01 (zabilugene almadenorepvec) the goal of which is to improve treatment outcomes in metastatic... ► Artikel lesen | |
| WAVE LIFE SCIENCES | 4,605 | -1,71 % | XFRA NEW INSTRUMENTS AVAILABLE ON 10.08.2026 | The following instruments on XETRA do have their first trading 10.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.08.2026
Aktien
1 KYG472811036 IMC Rare Earths Ltd.
2... ► Artikel lesen | |
| TUHURA BIOSCIENCES | 2,100 | -1,87 % | TuHURA Biosciences, Inc.: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | TAMPA, Fla., Aug. 14, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel... ► Artikel lesen | |
| THERAPEUTICSMD | 1,740 | +0,58 % | TherapeuticsMD, Inc. - 10-Q, Quarterly Report | ||
| SKYE BIOSCIENCE | 0,426 | 0,00 % | XFRA 09R: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSKYE BIOSCIENCE... ► Artikel lesen |